Advanced Filter

Filter by Group

Filter by Market Availability

Displaying 1 drug
Rasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.
Approved
Displaying 1 drug